Efecto neuroprotector de una formulación nasal de eritropoyetina con bajo contenido de ácido siálico

Nuñez Figueredo, Yanier; Bueno Pavón, Viviana; Carrillo Domínguez, Carmen; Jiménez Alemán, Narda; Valdés Martínez, Odalys; Montero Alejo, Vivian; Muñoz Cernuda, Adriana; Alonso Jiménez, Esther.
Rev. cuba. farm ; 43(1)ene.-abr. 2009. ilus, graf
Artículo en Español | LILACS | ID: lil-531416

Documentos relacionados

  1. A novel nano material for anti-cerebral ischaemia: preparation and application of borneol angelica polysaccharide liposomes.
  2. [Research progress of ion channels relating to cerebral ischemic diseases and prevention and treatment with traditional Chinese medicine].
  3. Ulinastatin affects focal cerebral ischemia-reperfusion injury via SOCS1-mediated JAK2/STAT3 signalling pathway.
  4. In vivo study of the utility of selective intra-arterial injection of thiopental for neuroprotection in reversible cerebral ischemia.
  5. Regulation of Tau protein phosphorylation by glucosamine-induced O-GlcNAcylation as a neuroprotective mechanism in a brain ischemia-reperfusion model.
  6. Experimental Study: The Effect Of 20% Intralipid Emulsion Therapy In Cerebral Ischemic Reperfusion.
  7. [Mechanism of Chuanxiong Rhizoma-Paeoniae Radix Rubra drug pair on intervention of cerebral ischemia based on network pharmacology-molecular docking].
  8. [The Peptide Drug ACTH(4-7)PGP (Semax) Suppresses mRNA Transcripts Encoding Proinflammatory Mediators Induced by Reversible Ischemia of the Rat Brain].
  9. Neuroprotective effect of Potentilla reptans L. root in the rat brain global ischemia/reperfusion model.
  10. Roflumilast protects against spatial memory impairments and exerts anti-inflammatory effects after transient global cerebral ischemia.